Clinical trial
Outline of Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
NCT02600468 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outline of Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- December 31, 2015
- Enrollment
- 671 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis